Dr. Gabriel Axelrud

Claim this profile

Covenant Medical Center-Lakeside

Studies Tumors
Studies Brain Tumor
3 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Covenant Medical Center-Lakeside

Clinical Trials Gabriel Axelrud is currently running

Image of trial facility.

Surgery and Radiation vs. Radiation Alone

for Brain Cancer

This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.
Recruiting2 awards Phase 3
Image of trial facility.

Whole Brain Radiotherapy + Stereotactic Radiosurgery

for Brain Metastasis

This phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery versus stereotactic radiosurgery alone in treating patients with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery. Hippocampus avoidance during whole-brain radiation therapy decreases the amount of radiation that is delivered to the hippocampus, which is a brain structure that is important for memory. The medicine memantine is also often given with whole brain radiation therapy because it may decrease the risk of side effects of radiation on thinking and memory. Stereotactic radiosurgery delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery may be effective in shrinking or stabilizing cancer that has spread to the brain and returned in other areas of the brain after receiving stereotactic radiosurgery.
Recruiting2 awards Phase 312 criteria

More about Gabriel Axelrud

Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Gabriel Axelrud has experience with
  • Stereotactic Radiosurgery
  • Relugolix
  • Stereotactic Body Radiation Therapy
  • Brain Surgery
  • Whole-Brain Radiotherapy
  • Memantine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gabriel Axelrud specialize in?
Gabriel Axelrud focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are undergoing treatment.
Is Gabriel Axelrud currently recruiting for clinical trials?
Yes, Gabriel Axelrud is currently recruiting for 3 clinical trials in Lubbock Texas. If you're interested in participating, you should apply.
Are there any treatments that Gabriel Axelrud has studied deeply?
Yes, Gabriel Axelrud has studied treatments such as Stereotactic Radiosurgery, Relugolix, Stereotactic Body Radiation Therapy.
What is the best way to schedule an appointment with Gabriel Axelrud?
Apply for one of the trials that Gabriel Axelrud is conducting.
What is the office address of Gabriel Axelrud?
The office of Gabriel Axelrud is located at: Covenant Medical Center-Lakeside, Lubbock, Texas 79410 United States. This is the address for their practice at the Covenant Medical Center-Lakeside.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.